
    
      This study was a single dose, randomized, two period, two treatment, two sequence crossover
      study design was used to evaluate the relative bioavailability of Fosinopril sodium and
      hydrochlorothiazide tablet products when dose (1 x 20-12.5 mg) under fasting conditions. The
      two periods of the study were separated by a washout period of at least a week.

      A total of 36 healthy adult subjects were enrolled in the study. Of all the subjects 34
      subjects (21 males and 13 females) completed the study.
    
  